Christopher Graham Torell, PA

Christopher Torell practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Christopher Torell's NPI, 1649945742, was assigned on August 11, 2021. Christopher Torell holds New York license 026735.

Christopher Torell's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Christopher Torell's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Christopher Torell is also affiliated with St. Joseph's Health Hospital. The medical group on file is Upstate University Hospital. Dmand AI also links Christopher Torell to 1 more hospital, 2 medical groups and 1 therapy and rehab clinic, each named with a free account. Christopher Torell's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Torell practices, 4 sites in all. Vendor and product names are available with a free account.

Medical is Christopher Torell's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Christopher Torell is licensed in New York.

CMS counts 61 Medicare patients who saw Christopher Torell in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Torell's median patient age at 67, with 40% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Christopher Torell for performance year 2024, reported through an alternative payment model (APM). Christopher Torell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Christopher Torell from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $127.